Loading clinical trials...
Loading clinical trials...
A Phase I/II Study of Lenalidomide Maintenance After Autologous Stem Cell Transplant for Elderly Patients With Acute Myeloid Leukemia (AML)
Conditions
Interventions
Laboratory Biomarker Analysis
Lenalidomide
Locations
3
United States
Albert Einstein College of Medicine
The Bronx, New York, United States
Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States
Start Date
December 1, 2013
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2016
Last Updated
May 14, 2020
NCT03874052
NCT03128034
NCT04284787
NCT04190550
NCT04269213
NCT03330821
Lead Sponsor
Albert Einstein College of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions